Citation Impact
Citing Papers
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
2009 StandoutScience
Interleukin 37 expression protects mice from colitis
2011
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
2005 Science
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
2001
Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
2011
Cytokines in inflammatory bowel disease
2014 Standout
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Maintenance treatment of Crohn's disease
2003
Immune cell migration in inflammation: present and future therapeutic targets
2005
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Management of Crohn's disease in adults
2001
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
The Size of the Unstirred Layer as a Function of the Solute Diffusion Coefficient
1998
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
2011
The fundamental basis of inflammatory bowel disease
2007
Mucosal healing as an index of colitis activity: Back to histological healing for future indices
2010
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
2011
Water and Ion Permeation of Aquaporin-1 in Planar Lipid Bilayers
2001 StandoutNobel
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis
2010
Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
2002
Review article: infliximab therapy for inflammatory bowel disease – seven years on
2006
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
2009
Importance of mucosal healing in ulcerative colitis
2009
Ulcerative Colitis
2011 Standout
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease
2006
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
2008
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Adherent-Invasive Escherichia coli Induce Claudin-2 Expression and Barrier Defect in CEABAC10 Mice and Crohnʼs Disease Patients§
2011
Long-term treatment of rectovaginal fistulas in Crohn’s disease: Response to infliximab in the ACCENT II Study
2004
Correlations of C-reactive Protein Levels and Erythrocyte Sedimentation Rates with Endoscopic Activity Indices in Patients with Ulcerative Colitis
2013
Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production
2010
Cryopyrin activates the inflammasome in response to toxins and ATP
2006 StandoutNature
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
2008
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
2005
Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis
2007
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
2009
Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55
2004
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
2016
Pattern Recognition Receptors and Inflammation
2010 Standout
CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, for steroid‐dependent Crohn's disease: a randomized, double‐blind, placebo‐controlled trial
2006
How Rapidly Should Remission Be Achieved?
2010
New Approaches to Gene Hunting in IBD
2004
Anti-TNF-alpha therapy in ankylosing spondylitis
2006
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
2011
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease
2005
Epidemiology and risk factors for IBD
2015 Standout
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
2013
Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease
2009
Optimizing the safety of biologic therapy for IBD
2010
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
2013
IBD5 is a General Risk Factor for Inflammatory Bowel Disease: Replication of Association with Crohn Disease and Identification of a Novel Association with Ulcerative Colitis
2003
Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis
2013
Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
2006
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
2013
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Mechanisms in failure of infliximab for Crohn's disease
2000
Biological Therapies for Inflammatory Bowel Diseases
2009
Future biologic targets for IBD: potentials and pitfalls
2010
Neutrophils and immunity: challenges and opportunities
2006 Standout
Inflammation and Colon Cancer
2010 Standout
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
2006
European consensus on the histopathology of inflammatory bowel disease
2013
Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?
2005
Biology of Incretins: GLP-1 and GIP
2007 Standout
Adalimumab for the treatment of fistulas in patients with Crohn’s disease
2009
SNAP receptors implicated in vesicle targeting and fusion
1993 StandoutNatureNobel
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial
2006
Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin
2003
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
2012
Comparison Between the Natural Postnatal Maturation and the Spermine-Induced Maturation of the Rat Intestine
1998
Immunity, Inflammation, and Cancer
2010 Standout
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
2012
A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
2012
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate
2006
Certolizumab Pegol for the Treatment of Crohn's Disease
2007
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Diagnostics of Inflammatory Bowel Disease
2007
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial
2006
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?
2013
TNFR2 Activates MLCK-Dependent Tight Junction Dysregulation to Cause Apoptosis-Mediated Barrier Loss and Experimental Colitis
2013
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
Ulcerative colitis
2009
Spermine Induces Maturation of the Immature Intestinal Immune System in Neonatal Mice
1997
Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trial
1996
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
2006
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
2006
Origin and physiological roles of inflammation
2008 StandoutNature
Evolving knowledge and therapy of inflammatory bowel disease
2006
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
2009
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
2009
Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
2011
A microbial symbiosis factor prevents intestinal inflammatory disease
2008 StandoutNature
Analysis of structural and biochemical events occurring in the small intestine after dietary polyamine ingestion in suckling rats
1996
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
2002
Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy
2013
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
2007
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease
2001
Tumour necrosis factor and cancer
2009
Lessons to be learned from the NOD2 gene in Crohn's disease
2003
Genome-wide association studies for common diseases and complex traits
2005 Standout
Repifermin (keratinocyte growth factor‐2) for the treatment of active ulcerative colitis: a randomized, double‐blind, placebo‐controlled, dose‐escalation trial
2003
Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease
2005
Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s disease
2003
Cancer-related inflammation
2008 StandoutNature
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013
A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease
2006
Genetics of ulcerative colitis
2010
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
2006
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Pathogen Recognition and Innate Immunity
2006 Standout
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
Guidelines for the management of inflammatory bowel disease in adults
2004
The plant immune system
2006 StandoutNature
An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Prior Loss of Response or Intolerance to Infliximab for Crohn's Disease
2004
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Adherence to Medication
2005 Standout
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
The use of fecal calprotectin and lactoferrin in patients with IBD. Review.
2013
Methotrexate for induction of remission in refractory Crohn's disease
2014
Maintenance Therapy in Crohn's Disease
2000
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
2018
A Conventional Beagle Dog Model for Acute and Chronic Infection withHelicobacter pylori
1999
TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells
2009
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
2008 StandoutNature
Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
2013
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis
2003
Methotrexate for maintenance of remission in Crohn's disease
2014
A comparison of randomised controlled trials in health and education
2005
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Short-Chain Fatty Acids Impact on Intestinal Adaptation, Inflammation, Carcinoma, and Failure
2006
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular transport.
1988 StandoutNobel
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis
2003
Spermidine in health and disease
2018 StandoutScience
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Influence of spermine on intestinal maturation of the glycoprotein glycosylation process in neonatal rats
1999
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
2014
Pathways of Protein Secretion in Eukaryotes
1985 Science
Clathrin: A Role in the Intracellular Retention of a Golgi Membrane Protein
1989 StandoutScienceNobel
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Budesonide for induction of remission in Crohn's disease
2015
A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum
1987 StandoutNobel
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
2008
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
2005
Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
2001
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Highly selective water channel activity measured by voltage clamp: Analysis of planar lipid bilayers reconstituted with purified AqpZ
2001 StandoutNobel
Homing imprinting and immunomodulation in the gut: Role of dendritic cells and retinoids
2007
CATERPILLER: A Novel Gene Family Important in Immunity, Cell Death, and Diseases
2004
Works of Gary Wild being referenced
Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrin
2005
Budesonide in the Management of Patients with Crohn’s Disease
1997
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
2000
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
2001
Predicting relapse in Crohn’s disease: a biopsychosocial model
2008
CARD15 Genetic Variation in a Quebec Population: Prevalence, Genotype-Phenotype Relationship, and Haplotype Structure
2002
Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review
2018
Short‐Chain Fatty Acids Increase Proglucagon and Ornithine Decarboxylase Messenger RNAs After Intestinal Resection in Rats
1996
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
2008
Onercept for Moderate-to-Severe Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
2006
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFα production and nuclear factor kappa B expression
2003
REVIEW: Small Bowel Review: Normal Physiology Part 2
2001
Effect of Exogenously Administered Polyamine on the Structural Maturation and Enzyme Ontogeny of the Postnatal Rat Intestine
1993
Psychological Distress, Social Support, and Disease Activity in Patients With Inflammatory Bowel Disease
2001
The Role of Antibiotics in the Management of Crohnʼs Disease
2004
Association of DLG5 R30Q variant with inflammatory bowel disease
2005
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
2000
Patient Nonadherence To Medication in Inflammatory Bowel Disease
2003
Methotrexate for the Treatment of Crohn's Disease
1995
REVIEW: Small Bowel Review: Normal Physiology Part 1
2001
Psychosocial correlates of patient-physician discordance in inflammatory bowel disease
2002
Tumor Necrosis Factor Receptor Gene Polymorphisms in Crohn's Disease: Association with Clinical Phenotypes
2005
Safety, tolerance and efficacy of multiple doses of subcutaneous interleukin-10 in mild to moderate active Crohn's disease (STAMM-CD)
1998
Efficacy and safety of a humanized α4β7 antibody in active crohn's disease (CD)
2003
A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn's disease (CACD)
1998
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
2000
Nutrients and intestinal adaptation.
1996
Detection of Helicobacter pylori infection by saliva IgG testing.
1996
An ascending dose trial of a humanized A4B7 antibody in ulcerative colitis (UC)
2000
Influence of colchicine and vinblastine on the intracellular migration of secretory and membrane glycoproteins: III. Inhibition of intracellular migration of membrane glycoproteins in rat intestinal columnar cells and hepatocytes as visualized by light and electron‐microscope radioautography after 3h‐fucose injection
1984
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
2006